Vimarsana
Biggest News Aggregation in the World

Page 31 - Multiple Sclerosis Ms News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multiple Sclerosis Ms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multiple Sclerosis Ms Today - Breaking & Trending Today

Modeling of Individual Neurophysiologic Brain Connectivity - Vimarsana News

Modeling of Individual Neurophysiologic Brain Connectivity

Researchers demonstrated individual functional connectivity patterns using structural data from weighted imaging and magnetoencephalography to predict neurologic disease trajectories.

Smoking, Drinking Tied to Increased MS Risk, More Severe Symptoms - Vimarsana News

Smoking, Drinking Tied to Increased MS Risk, More Severe Symptoms

High alcohol consumption can contribute to more severe neurodegeneration in multiple sclerosis — and smoking may increase risk for disease development, new research suggests.

Early MS Biomarkers May Improve Prediction of Long-term Outcomes - Vimarsana News

Early MS Biomarkers May Improve Prediction of Long-term Outcomes

Serum neurofilament light chain and glial fibrillary acidic protein levels can help improve outcome predictions in multiple sclerosis — and are linked to relapse risk after treatment discontinuation.

Keto diet helps people with multiple sclerosis reduce disability, improve quality of life - Vimarsana News

Keto diet helps people with multiple sclerosis reduce disability, improve quality of life

Keto diet helps people with multiple sclerosis reduce disability, improve quality of life - A recent study suggests that a ketogenic diet might be safe for people with multiple sclerosis.

B-Cell Therapy for MS May Affect COVID Vaccine Response - Vimarsana News

B-Cell Therapy for MS May Affect COVID Vaccine Response

Disease modifying therapies for multiple sclerosis, especially B-cell depleting drugs, are associated with a reduced humoral response to SARS-CoV-2 vaccines, new research suggests.